152 related articles for article (PubMed ID: 11493776)
1. Prognostic factors in clinical stage 1 non-seminomatous testicular tumours.
Witjes JA; Spermon JR
Curr Opin Urol; 2001 Sep; 11(5):531-4. PubMed ID: 11493776
[TBL] [Abstract][Full Text] [Related]
2. Surgery versus surveillance in stage I non-seminoma testicular cancer.
Sonneveld DJ; Koops HS; Sleijfer DT; Hoekstra HJ
Semin Surg Oncol; 1999 Dec; 17(4):230-9. PubMed ID: 10588851
[TBL] [Abstract][Full Text] [Related]
3. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Sheinfeld J
Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
[No Abstract] [Full Text] [Related]
4. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumors: review of selected studies from 2002.
Hellerstedt BA; Pienta KJ
Curr Opin Oncol; 2003 May; 15(3):234-8. PubMed ID: 12778018
[TBL] [Abstract][Full Text] [Related]
6. Advanced non-seminomatous germ cell cancer of the testis with brain metastases: feasibility of additional brain irradiation and whole body hyperthermia plus chemotherapy.
Feyerabend T; Wiedemann GJ; Steeves R
Oncol Rep; 2001; 8(2):219-23. PubMed ID: 11182030
[TBL] [Abstract][Full Text] [Related]
7. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
8. Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.
Al Ghamdi AM; Jewett MA
Can J Urol; 2005 Feb; 12 Suppl 1():62-5; discussion 103-4. PubMed ID: 15780169
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
[TBL] [Abstract][Full Text] [Related]
10. Treatment of metastatic nonseminomatous germ cell tumors of the testis: significance of the international consensus prognostic classification as a prognostic factor-based staging system.
Shinohara N; Hioka T; Harabayashi T; Demura T; Kashiwagi A; Nagamori S; Koyanagi T
Int J Urol; 1998 Nov; 5(6):562-7. PubMed ID: 9855125
[TBL] [Abstract][Full Text] [Related]
11. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
12. Treatment of disseminated non-seminomatous testicular cancer: the European experience.
de Wit R
Semin Surg Oncol; 1999 Dec; 17(4):250-6. PubMed ID: 10588853
[TBL] [Abstract][Full Text] [Related]
13. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
[TBL] [Abstract][Full Text] [Related]
14. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
Caty A; Depadt G; Feutry ML
Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
16. Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Terenziani M; Piva L; Spreafico F; Salvioni R; Massimino M; Luksch R; Cefalo G; Casanova M; Ferrari A; Polastri D; Mazza E; Bellani FF; Nicolai N
J Pediatr Hematol Oncol; 2002; 24(6):454-8. PubMed ID: 12218592
[TBL] [Abstract][Full Text] [Related]
17. Management of low-stage nonseminomatous germ cell tumors of the testis.
Steele GS; Richie JP
Compr Ther; 2000; 26(3):210-9. PubMed ID: 10984827
[TBL] [Abstract][Full Text] [Related]
18. Primary chemotherapy after orchidectomy for stage I and II nonseminoma.
Horwich A; Cullen MH; Stenning SP
Semin Oncol; 1998 Apr; 25(2):154-9. PubMed ID: 9562448
[TBL] [Abstract][Full Text] [Related]
19. 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Huddart RA; O'Doherty MJ; Padhani A; Rustin GJ; Mead GM; Joffe JK; Vasey P; Harland SJ; Logue J; Daugaard G; Hain SF; Kirk SJ; MacKewn JE; Stenning SP;
J Clin Oncol; 2007 Jul; 25(21):3090-5. PubMed ID: 17634488
[TBL] [Abstract][Full Text] [Related]
20. [Current procedure for treating testicular germ-cell tumors].
Tiuliandin SA; Figurin KM; Garin AM
Urol Nefrol (Mosk); 1995; (6):40-4. PubMed ID: 8686125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
